| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2
|
Sieiro Santos, C.
|
|
|
39 |
7 |
p. 2105-2106
|
article
|
| 2 |
Apolipoprotein C1 in synovial fluid discriminates septic arthritis from rheumatoid arthritis but not from pseudogout
|
Clapasson, Margot
|
|
|
39 |
7 |
p. 2239-2241
|
article
|
| 3 |
Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?
|
Vakil-Gilani, Kiana
|
|
|
39 |
7 |
p. 2067-2068
|
article
|
| 4 |
A tale of autoimmunity: thymoma, thymectomy, and systemic lupus erythematosus
|
Mollaeian, Arash
|
|
|
39 |
7 |
p. 2227-2234
|
article
|
| 5 |
Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis
|
Kucuk, Adem
|
|
|
39 |
7 |
p. 2103-2104
|
article
|
| 6 |
Catastrophic antiphospholipid syndrome: is life-long anticoagulation therapy required?
|
Mesa, Christopher J.
|
|
|
39 |
7 |
p. 2115-2119
|
article
|
| 7 |
Central nervous system involvement in patients with antineutrophil cytoplasmic antibody–associated vasculitis: a study of 29 cases in a single Chinese center
|
Ma, Tian-Tian
|
|
|
39 |
7 |
p. 2185-2193
|
article
|
| 8 |
Clinical image
|
Jansen, Tim L.
|
|
|
39 |
7 |
p. 2235-2236
|
article
|
| 9 |
Clinical phenotypes based on clinical prognostic factors in patients with secondary hip osteoarthritis: preliminary findings from a prospective cohort study
|
Tateuchi, Hiroshige
|
|
|
39 |
7 |
p. 2207-2217
|
article
|
| 10 |
Colchicine may not be effective in COVID-19 infection; it may even be harmful?
|
Cumhur Cure, Medine
|
|
|
39 |
7 |
p. 2101-2102
|
article
|
| 11 |
Comment on “A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis”
|
Akrapovic Olic, Ivna
|
|
|
39 |
7 |
p. 2243-2244
|
article
|
| 12 |
Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies
|
Asakawa, Katsuaki
|
|
|
39 |
7 |
p. 2171-2178
|
article
|
| 13 |
Correction to: Associations between serumIL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis
|
Ruan, Guangfeng
|
|
|
39 |
7 |
p. 2249
|
article
|
| 14 |
Correction to: A systematic review of internet-based information for individuals with Raynaud’s phenomenon and patients with systemic sclerosis
|
Devgire, Vikrant
|
|
|
39 |
7 |
p. 2247
|
article
|
| 15 |
Correction to: Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis
|
Barbosa-Cobos, Rosa Elda
|
|
|
39 |
7 |
p. 2245
|
article
|
| 16 |
Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review
|
Dai, Jinghong
|
|
|
39 |
7 |
p. 2031-2037
|
article
|
| 17 |
COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
|
Ouédraogo, Dieu-Donné
|
|
|
39 |
7 |
p. 2069-2075
|
article
|
| 18 |
COVID-19 with rheumatic diseases: a report of 5 cases
|
Cheng, Chuanfang
|
|
|
39 |
7 |
p. 2025-2029
|
article
|
| 19 |
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
|
Soy, Mehmet
|
|
|
39 |
7 |
p. 2085-2094
|
article
|
| 20 |
Diagnosing relapsing polychondritis remains a common challenge: experience from a Chinese retrospective cohort
|
Zhang, Lei
|
|
|
39 |
7 |
p. 2179-2184
|
article
|
| 21 |
High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia
|
Gazzaruso, Carmine
|
|
|
39 |
7 |
p. 2095-2097
|
article
|
| 22 |
Impact of thumb osteoarthritis on pain, function, and quality of life: a comparative study between erosive and non-erosive hand osteoarthritis
|
Tenti, Sara
|
|
|
39 |
7 |
p. 2195-2206
|
article
|
| 23 |
Management of antiphospholipid syndrome
|
Rahman, Anisur
|
|
|
39 |
7 |
p. 2111-2114
|
article
|
| 24 |
Navigating COVID-19 in the developing world
|
Hodkinson, Bridget
|
|
|
39 |
7 |
p. 2039-2042
|
article
|
| 25 |
Orbital compartment syndrome as the first manifestation of SLE
|
Colon, Maria
|
|
|
39 |
7 |
p. 2223-2226
|
article
|
| 26 |
Prevalence of anti-DFS70 autoantibodies in a Latin American cohort of patients with systemic lupus erythematosus and without autoimmune diseases
|
Aragón, Cristian C.
|
|
|
39 |
7 |
p. 2163-2169
|
article
|
| 27 |
Professor Luis R. Espinoza: a living legacy (1943–2020)
|
Jara, Luis J.
|
|
|
39 |
7 |
p. 2107-2110
|
article
|
| 28 |
Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis
|
Kaine, Jeffrey
|
|
|
39 |
7 |
p. 2127-2137
|
article
|
| 29 |
Relative efficacy and safety of iguratimod monotherapy for the treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
|
Shrestha, Sajan
|
|
|
39 |
7 |
p. 2139-2150
|
article
|
| 30 |
Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?
|
Ahmed, Sakir
|
|
|
39 |
7 |
p. 2099-2100
|
article
|
| 31 |
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
|
Misra, Durga Prasanna
|
|
|
39 |
7 |
p. 2055-2062
|
article
|
| 32 |
Serum adipokine levels in patients with sarcoidosis
|
Kobak, Senol
|
|
|
39 |
7 |
p. 2121-2125
|
article
|
| 33 |
Spatio-temporal evolution of onychomadesis in a child with missed Kawasaki disease
|
Banday, Aaqib Zaffar
|
|
|
39 |
7 |
p. 2237-2238
|
article
|
| 34 |
Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity
|
Minniti, Antonina
|
|
|
39 |
7 |
p. 2063-2065
|
article
|
| 35 |
The role of socioeconomic status in the susceptibility to develop systemic lupus erythematosus in Mexican patients
|
Salgado-Galicia, Norma Alicia
|
|
|
39 |
7 |
p. 2151-2161
|
article
|
| 36 |
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress
|
Orlandi, Martina
|
|
|
39 |
7 |
p. 2043-2047
|
article
|
| 37 |
TNF inhibitor treating osseous sarcoidosis and dactylitis: case and literature review
|
Alawneh, Diala
|
|
|
39 |
7 |
p. 2219-2222
|
article
|
| 38 |
Treatment algorithm for COVID-19: a multidisciplinary point of view
|
Galluccio, Felice
|
|
|
39 |
7 |
p. 2077-2084
|
article
|
| 39 |
YouTube as a source of information on COVID-19 and rheumatic disease link
|
Kocyigit, Burhan Fatih
|
|
|
39 |
7 |
p. 2049-2054
|
article
|
Journal description